You are here

Palatin Technologies

Palatin CEO claims ‘a positive study on its face,’ despite dry eye drug's primary endpoint miss

Fierce Biotech

Wed, 02/28/24 - 10:49 am

Palatin Technologies

dry eye disease

clinical trials

Palatin sells female libido drug Vyleesi to Cosette for $12M, plus more in potential milestones

Fierce Pharma

Wed, 12/20/23 - 06:34 pm

Palatin Technologies

female sexual dysfunction

Palatin enrols first subject in Phase II ulcerative colitis therapy trial

Clinical Trials Arena

Fri, 10/21/22 - 10:41 am

Palatin Technologies

ulcerative colitis

clinical trials